| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/29/2004 | CN1168693C Substituted phenols and thiophenols useful as antioxidant agents |
| 09/29/2004 | CN1168492C Use of activated protein C in porducing medicine and unit formulation containing activated protein C |
| 09/29/2004 | CN1168489C Skin-haemorrhoids-clearing ointmenta nd preparing method thereof |
| 09/29/2004 | CN1168483C Heart disease treating medicine |
| 09/29/2004 | CN1168481C Xin-non-ning capsule for treating cardio-vascular and cerebral vascular disease and its preparing process |
| 09/29/2004 | CN1168473C Chines medicine prepn for treating arterioscleriosis |
| 09/29/2004 | CN1168469C Chinese medicine composition for curing cardiovascular disease |
| 09/29/2004 | CN1168465C Chinese medicine granular for treating cardiac and cerebral diseases and its prepn |
| 09/29/2004 | CN1168463C Injection for treating cerebral thrombus and preparation thereof |
| 09/29/2004 | CN1168462C Oral liquid capable of reducing blood fat and improving symptom of myocardial ischemia and infarction |
| 09/29/2004 | CN1168447C Use of oxazolidinones for preparation of medicament for transdermal delivery |
| 09/29/2004 | CN1168446C Application of arecaline hydrobromide as medicine for arrhythmia |
| 09/29/2004 | CN1168445C Concentrated clear solution contg. biocefalin as brain metabolism improving medicine for intravenous injection after diluting it |
| 09/29/2004 | CN1168444C Nifedipine drop pill preparation and its making method |
| 09/29/2004 | CN1168442C Methods and compsns. for stimulating neurite growth |
| 09/28/2004 | US6797727 Such as restenosis and atherosclerosis. |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/28/2004 | US6797699 Exemplified by n'-l-arginylspermidine |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6797285 Leaves of Cajanus Cajan(L.) Millsp and extract, formulation and uses thereof |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/23/2004 | WO2004081046A2 Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis |
| 09/23/2004 | WO2004081009A1 Quinazoline derivatives as tgf-beta inhibitors |
| 09/23/2004 | WO2004081001A1 Novel 2-pyridinecarboxamide derivatives |
| 09/23/2004 | WO2004080933A2 Isolation of lutein from alfalfa |
| 09/23/2004 | WO2004080503A1 Compositions for use in embolizing blood vessels comprising high levels of contrast agent |
| 09/23/2004 | WO2004080482A2 Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure |
| 09/23/2004 | WO2004080452A1 Remedies for retinal diseases |
| 09/23/2004 | WO2004080375A2 Vaccine therapy of atherosclerosis |
| 09/23/2004 | WO2004069150A3 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides |
| 09/23/2004 | WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | WO2003063782A3 Kappa-pviia-related conotoxins as organ protectants |
| 09/23/2004 | WO2003059436A3 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 09/23/2004 | WO2003046204A3 Humanized collagen antibodies and related methods |
| 09/23/2004 | US20040186587 Devices and methods for treating tissue |
| 09/23/2004 | US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186277 Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186163 Novel combination |
| 09/23/2004 | US20040186158 Novel composition of carvedilol |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186150 4-{5-[4-(5-Isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine (DW-1350); a leukotriene-B4 receptor antangonist; inhibiting osteoclastic bone absorption |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186136 E.g., mono-, poly- or perdeuteriated tolperisone and eperisone; appreciably better pharmacokinetic and/or pharmacodynamic properties than the undeuterated compounds; muscular disorders; muscle relaxants (skeletal); antispasmodic agents; vasodilation |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/23/2004 | US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 09/23/2004 | US20040186109 piperazine derivatives, e.g., (2R)-1-(2-methylbenzothiazol-5-yloxy)-3-[4-({5-[4-(trifluoromethyl)phenyl](4,5-dihydroisoxazol-3-yl)}methyl)piperazinyl]propan-2-ol; treating diabetes, arrhythmia, intermittent claudication, angina, congestive heart disease, and myocardial infarction |
| 09/23/2004 | US20040186106 such as (S)-N-{{(1R, 2R)-2-{4-{[2-(4-Methyl-piperazin-1-yl)-benzimidazol-1-yl]methyl}-phenyl}-cyclohex-1-yl} carbonyl}-phenylglycinamide; for treatment of ischemic brain disorders |
| 09/23/2004 | US20040186104 Novel pyridinone and related heterocyclic derivatives |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186073 Use of a phosphate adsorbent to combat vascular diseases |
| 09/23/2004 | US20040186049 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185533 Corticotropin-releasing factor2 receptors |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185439 using polymorphisms to determine susceptibility cancer, osteoporosis, cardiovascular disorders; for drug screening |
| 09/23/2004 | US20040185129 Salvia hispanica l (chia) in the management and treatment of cardiovascular disease diabetes and asociated risk factors |
| 09/23/2004 | US20040185128 Use of an extract of the root of balloon-flower for preventing and treating a degenerative brain disease or for enhancing memory |
| 09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
| 09/23/2004 | US20040185113 Sparingly water-soluble calcium-containing inorganic microparticles and a drug or biodrug encapsulated therein; made by adding a calcium compound to a solution of a carbonate, phosphate, oxalate or urate and the drug to form the calcium salt of the carbonate, phosphate, oxalate or urate |
| 09/23/2004 | US20040185044 Use of human antibody which recognises apolipoprotein CIII; atherosclerosis or dyslipidaemia treatment; passive vaccination |
| 09/23/2004 | CA2510678A1 Compositions for use in embolizing blood vessels comprising high levels of contrast agent |
| 09/22/2004 | EP1460084A1 Novel peptide sy |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1460072A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1459763A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 09/22/2004 | EP1459759A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 09/22/2004 | EP1459752A2 Bisdioxopiperazine for the treatment of accidental extravasation of anthracyclines |
| 09/22/2004 | EP1459738A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 09/22/2004 | EP1458870A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458748A2 Apoptotically active peptides |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 09/22/2004 | EP1458719A1 Pyridoquinoxaline antivirals |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458713A1 Indolinone derivatives useful as protein kinase inhibitors |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458711A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 09/22/2004 | EP1458707A2 New compounds |
| 09/22/2004 | EP1458702A1 Luminacin analogs and uses thereof |